Safety of Recombinant Activated Factor VII in Randomized Clinical Trials New England Journal of Medicine BPC 157: Miracle Healing Peptide or Hidden Danger? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is the lack of human data in BPC 157 a red flag? If a drug could actually knit torn tendons back together in weeks, a trillion dollar pharmaceutical industry probably wouldn't bury FDA to Convene Expert Panel on Expanding Access to Peptides Amid Safety, Regulatory Debate AJMC The FDA's Current Position on Peptides Explained Holt Law